<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38806678</PMID><DateCompleted><Year>2024</Year><Month>08</Month><Day>19</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>17</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1546-170X</ISSN><JournalIssue CitedMedium="Internet"><Volume>30</Volume><Issue>8</Issue><PubDate><Year>2024</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Nature medicine</Title><ISOAbbreviation>Nat Med</ISOAbbreviation></Journal><ArticleTitle>Generating clinical evidence for treatment and prevention options for long COVID.</ArticleTitle><Pagination><StartPage>2109</StartPage><EndPage>2110</EndPage><MedlinePgn>2109-2110</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41591-024-03031-5</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Buchholz</LastName><ForeName>Stephanie</ForeName><Initials>S</Initials><Identifier Source="ORCID">0009-0007-8750-9684</Identifier><AffiliationInfo><Affiliation>European Medicines Agency, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Federal Institute for Drugs and Medical Devices, Bonn, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Meco</LastName><ForeName>Eugenia</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>European Medicines Agency, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>EMA Emergency Task Force, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ba&#x142;kowiec-Iskra</LastName><ForeName>Ewa Z</ForeName><Initials>EZ</Initials><Identifier Source="ORCID">0000-0001-8882-9769</Identifier><AffiliationInfo><Affiliation>EMA Emergency Task Force, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Experimental and Clinical Pharmacology, Medical University of Warsaw, Warsaw, Poland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Office for Registration of Medicinal Products, Medical Devices and Biocidal Products, Warsaw, Poland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>EMA Committee for Medicinal Products for Human Use, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sepodes</LastName><ForeName>Bruno</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-2761-0955</Identifier><AffiliationInfo><Affiliation>EMA Emergency Task Force, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>EMA Committee for Medicinal Products for Human Use, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculdade de Farm&#xe1;cia, Universidade de Lisboa, Lisbon, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cavaleri</LastName><ForeName>Marco</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-8246-755X</Identifier><AffiliationInfo><Affiliation>European Medicines Agency, Amsterdam, The Netherlands. Marco.Cavaleri@ema.europa.eu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>EMA Emergency Task Force, Amsterdam, The Netherlands. Marco.Cavaleri@ema.europa.eu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Nat Med</MedlineTA><NlmUniqueID>9502015</NlmUniqueID><ISSNLinking>1078-8956</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000093485" MajorTopicYN="N">COVID-19 Drug Treatment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>8</Month><Day>20</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>5</Month><Day>29</Day><Hour>0</Hour><Minute>49</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>5</Month><Day>28</Day><Hour>23</Hour><Minute>31</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38806678</ArticleId><ArticleId IdType="doi">10.1038/s41591-024-03031-5</ArticleId><ArticleId IdType="pii">10.1038/s41591-024-03031-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization. https://go.nature.com/3UZjXtm (2023).</Citation></Reference><Reference><Citation>Davis, H. E. et al. EClinicalMedicine 38, 101019 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId><ArticleId IdType="pmc">8280690</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis, H. E., McCorkell, L., Vogel, J. M. &amp; Topol, E. Nat. Rev. Microbiol. 21, 133&#x2013;146 (2023).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId><ArticleId IdType="pmc">9839201</ArticleId></ArticleIdList></Reference><Reference><Citation>European Medicines Agency. https://go.nature.com/3wpJzXc (2023).</Citation></Reference><Reference><Citation>European Medicines Agency. EMA/340269/2023; https://go.nature.com/44GYMQf (2023).</Citation></Reference><Reference><Citation>Klein, J. et al. Nature 623, 139&#x2013;148 (2023).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-023-06651-y</ArticleId><ArticleId IdType="pubmed">37748514</ArticleId><ArticleId IdType="pmc">10620090</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano, J. B., Murthy, S., Marshall, J. C., Relan, P. &amp; Diaz, J. V. Lancet Infect. Dis. 22, e102&#x2013;e107 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention (CDC). https://go.nature.com/3wnOUhL (2023).</Citation></Reference><Reference><Citation>National Institute for Health and Care Excellence (NICE). https://www.nice.org.uk/guidance/ng188/ (2022).</Citation></Reference><Reference><Citation>Frere, J. J. et al. Sci. Transl. 14, eabq3059 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abq3059</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>